Bruce & Co., Inc.
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 11, 2025), Bruce & Co., Inc. reported 39 stock positions worth $309.9 million. Its top holding was U-Haul Holding Co.-Non Voting (UHAL.B) at 9.7% of the portfolio, followed by Allstate (ALL, 8.1%) and Abbvie (ABBV, 7.9%). Compared with Q3 2024, it opened 1 new position, sold out of 1, added to 1 and reduced 20. The biggest buy was Aercap (AER, shares +88%) and the biggest sale U-Haul Holding Co.-Non Voting (UHAL.B, shares −8%).
- Most Recent 13F
- Q2 2026
- Location
- CHICAGO, IL
- CIK
- 0001358331
- Portfolio Value
- $309.9M (Q4 2024)
- SEC Filing
- 0001104659-25-011296 ↗ filed Feb 11, 2025
Holdings Value
Holdings 39 stocks · $309.9M
| UHAL.B U-Haul Holding Co.-Non Voting | 9.65% | 467,000 | $29.9M | Reduce -8.0% |
| ALL Allstate Corp. | 8.12% | 130,500 | $25.2M | No change |
| ABBV Abbvie Inc. | 7.88% | 137,500 | $24.4M | Reduce -6.1% |
| Nextera Energy filed as FPL GROUP INC | 7.29% | 315,000 | $22.6M | Reduce -5.5% |
| MRK Merck & Co Inc | 6.83% | 212,800 | $21.2M | Reduce -0.8% |
| DUK Duke Energy Corp. | 6.81% | 195,816 | $21.1M | No change |
| CMS CMS Energy Corp. | 6.15% | 286,000 | $19.1M | Reduce -7.7% |
| T AT&T Inc. | 5.68% | 773,000 | $17.6M | Reduce -21.4% |
| ABT Abbott Laboratories | 5.41% | 148,300 | $16.8M | Reduce -2.6% |
| AER Aercap Holdings NV | 4.63% | 150,000 | $14.4M | Add +87.5% |
| XEL Xcel Energy Inc. | 4.24% | 194,500 | $13.1M | Reduce -0.8% |
| AAPL Apple Inc. | 3.14% | 38,900 | $9.7M | Reduce -2.0% |
| IIIN Insteel Industries Inc. | 2.99% | 343,423 | $9.3M | No change |
| AVA Avista Corp. | 2.38% | 201,500 | $7.4M | No change |
| PFE Pfizer Inc. | 2.33% | 271,900 | $7.2M | Reduce -1.6% |
| BG Bunge Global SA | 2.01% | 80,000 | $6.2M | No change |
| UHAL U-Haul Holding Co. | 1.65% | 73,900 | $5.1M | Reduce -1.6% |
| ADM Archer-Daniels-Midland Co. | 1.63% | 100,000 | $5.1M | No change |
| DAR Darling Ingredients Inc. | 1.53% | 141,000 | $4.8M | Reduce -29.9% |
| NEM Newmont Corp. | 1.20% | 100,000 | $3.7M | No change |
| VICR Vicor Corp. | 1.09% | 70,000 | $3.4M | No change |
| RLI Rli Corp. | 1.08% | 20,400 | $3.4M | Reduce -8.9% |
| KOD Kodiak Sciences Inc. | 1.04% | 323,000 | $3.2M | Reduce -23.6% |
| SUPN Supernus Pharmaceuticals Inc. | 0.96% | 82,105 | $3.0M | No change |
| LLY Eli Lilly & Co. | 0.50% | 2,000 | $1.5M | New |
| PSNL Personalis Inc. | 0.47% | 253,000 | $1.5M | Reduce -15.7% |
| VALEANT PHARMACEUTICALS INTL filed as Bausch Health | 0.44% | 171,000 | $1.4M | Reduce -62.0% |
| SIRI Sirius XM Holdings Inc. | 0.41% | 55,784 | $1.3M | No change |
| MNKD Mannkind Corp. | 0.40% | 195,073 | $1.3M | No change |
| FOCL Edap TMS SA -ADR | 0.39% | 553,652 | $1.2M | No change |
| ASH Ashland LLC | 0.35% | 15,000 | $1.1M | No change |
| LVTX Lava Therapeutics NV | 0.24% | 771,874 | $733K | No change |
| VTRS Viatris Inc. | 0.23% | 58,279 | $726K | Reduce -0.9% |
| IGMS Igm Biosciences Inc. | 0.20% | 100,000 | $611K | No change |
| FATE Fate Therapeutics Inc. | 0.19% | 350,000 | $578K | No change |
| OGN Organon & Co. | 0.15% | 31,200 | $466K | Reduce -0.5% |
| CRBU Caribou Biosciences Inc. | 0.13% | 250,000 | $398K | Reduce -16.7% |
| WEC WEC Energy Group Inc. | 0.12% | 3,945 | $371K | Reduce -12.5% |
| MASS 908 Devices Inc. | 0.05% | 68,286 | $150K | No change |
Other holdings (2): bonds, preferreds, convertibles and warrants · $1.5M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| ACCELERATE DIAGNOSTICS (AXDX 5 12/15/26) | NOTE 5.000%12/1 · principal | 3,292,574 | $1.3M | Add +2.5% |
| Acorda Theraputics | Cv 6.0% · principal | 5,000,000 | $200K | No change |
Total filed on the 13F, all lines: $311.4M.
Portfolio Sells Q3 2024 → Q4 2024
| UHAL.B U-Haul Holding Co.-Non Voting | Reduce -8.0% | 9.65% | −1.03 |
| Nextera Energy | Reduce -5.5% | 7.29% | −0.95 |
| DAR Darling Ingredients Inc. | Reduce -29.9% | 1.53% | −0.65 |
| T AT&T Inc. | Reduce -21.4% | 5.68% | −0.65 |
| VALEANT PHARMACEUTICALS INTL | Reduce -62.0% | 0.44% | −0.63 |
| ABBV Abbvie Inc. | Reduce -6.1% | 7.88% | −0.57 |
| MRK Merck & Co Inc | Reduce -0.8% | 6.83% | −0.29 |
| CMS CMS Energy Corp. | Reduce -7.7% | 6.15% | −0.25 |
| UHAL U-Haul Holding Co. | Reduce -1.6% | 1.65% | −0.05 |
| CRBU Caribou Biosciences Inc. | Reduce -16.7% | 0.13% | −0.04 |
| WBD Warner Bros Discovery Inc. | Sold out | 0.00% | −0.03 |
| OGN Organon & Co. | Reduce -0.5% | 0.15% | −0.03 |
| PFE Pfizer Inc. | Reduce -1.6% | 2.33% | −0.01 |
| WEC WEC Energy Group Inc. | Reduce -12.5% | 0.12% | −0.01 |
| PSNL Personalis Inc. | Reduce -15.7% | 0.47% | +0.00 |
| VTRS Viatris Inc. | Reduce -0.9% | 0.23% | +0.03 |
| RLI Rli Corp. | Reduce -8.9% | 1.08% | +0.07 |
| ABT Abbott Laboratories | Reduce -2.6% | 5.41% | +0.34 |
| AAPL Apple Inc. | Reduce -2.0% | 3.14% | +0.44 |
| XEL Xcel Energy Inc. | Reduce -0.8% | 4.24% | +0.50 |
| KOD Kodiak Sciences Inc. | Reduce -23.6% | 1.04% | +0.71 |
Portfolio Buys Q3 2024 → Q4 2024
Notes & Other Activity Q3 2024 → Q4 2024
| ACCELERATE DIAGNOSTICS (AXDX 5 12/15/26) | NOTE 5.000%12/1 · principal | Add +2.5% | 3,292,574 | $1.3M |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 41 | $369.5M | ABBV, ALL, AER, Nextera Energy, MRK |
| Q1 2026 | 41 | $349.7M | Nextera Energy, ABBV, ALL, AER, MRK |
| Q4 2025 | 39 | $322.5M | ABBV, AER, ALL, Nextera Energy, UHAL.B |
| Q3 2025 | 39 | $322.9M | ABBV, ALL, Nextera Energy, UHAL.B, AER |
| Q2 2025 | 40 | $307.8M | ALL, UHAL.B, ABBV, Nextera Energy, AER |
| Q1 2025 | 41 | $310.5M | UHAL.B, ABBV, ALL, Nextera Energy, DUK |
| Q4 2024 | 39 | $309.9M | UHAL.B, ALL, ABBV, Nextera Energy, MRK |
| Q3 2024 | 39 | $342.1M | UHAL.B, ABBV, Nextera Energy, ALL, MRK |
| Q2 2024 | 38 | $299.2M | UHAL.B, MRK, ABBV, Nextera Energy, ALL |
| Q1 2024 | 37 | $297.1M | UHAL.B, MRK, ABBV, ALL, DUK |